Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 May;91(5):1997–2003. doi: 10.1172/JCI116421

Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.

J Galitzky 1, M Lafontan 1, J Nordenström 1, P Arner 1
PMCID: PMC288197  PMID: 8387538

Abstract

The role of alpha-2 adrenoceptors in lipid mobilization and blood flow was investigated in situ using microdialysis of subcutaneous adipose tissue in nonobese healthy subjects. The alpha-2 agonist clonidine caused dose-dependent biphasic response with increased glycerol levels at low clonidine concentrations and decreased glycerol levels at concentrations > 10(-7) mol/liter. Similar results were observed with epinephrine plus propranolol. Clonidine action was unaffected in the presence of labetalol (beta-/alpha-1 antagonist) but completely blunted by the presence of yohimbine (alpha-2 antagonist). The pseudolipolytic effect of clonidine was significantly more pronounced in gluteal as compared with abdominal adipose tissue. When clonidine was added together with the vasodilating agents nitroprusside or hydralazine, the pseudolipolytic effect was abolished and a dose-dependent decrease in dialysate glycerol was observed at all clonidine concentrations (10(-10)-10(-4) mol/liter). When ethanol was added to the perfusate to monitor blood flow, the escape of alcohol from the dialysate was accelerated by 30% with hydralazine or nitroprusside (P < 0.01) and 30% retarded (P < 0.05) by clonidine (10(-10) mol/liter). Thus, the results demonstrate an important role of blood flow for regulating lipid mobilization from adipose tissue in vivo. Alpha-2 adrenoceptor activation causes marked retention of lipids in adipose tissue due to vasoconstriction in combination with antilipoiysis.

Full text

PDF
1997

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arner P., Bolinder J., Eliasson A., Lundin A., Ungerstedt U. Microdialysis of adipose tissue and blood for in vivo lipolysis studies. Am J Physiol. 1988 Nov;255(5 Pt 1):E737–E742. doi: 10.1152/ajpendo.1988.255.5.E737. [DOI] [PubMed] [Google Scholar]
  2. Arner P., Kriegholm E., Engfeldt P., Bolinder J. Adrenergic regulation of lipolysis in situ at rest and during exercise. J Clin Invest. 1990 Mar;85(3):893–898. doi: 10.1172/JCI114516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arner P., Kriegholm E., Engfeldt P. In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis. J Pharmacol Exp Ther. 1990 Jul;254(1):284–288. [PubMed] [Google Scholar]
  4. Arner P., Kriegholm E., Engfeldt P. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. J Pharmacol Exp Ther. 1991 Oct;259(1):317–322. [PubMed] [Google Scholar]
  5. Bolinder J., Hagström E., Ungerstedt U., Arner P. Microdialysis of subcutaneous adipose tissue in vivo for continuous glucose monitoring in man. Scand J Clin Lab Invest. 1989 Sep;49(5):465–474. doi: 10.1080/00365518909089123. [DOI] [PubMed] [Google Scholar]
  6. Burns T. W., Langley P. E., Terry B. E., Bylund D. B., Hoffman B. B., Tharp M. D., Lefkowitz R. J., García-Saínz J. A., Fain J. N. Pharmacological characterizations of adrenergic receptors in human adipocytes. J Clin Invest. 1981 Feb;67(2):467–475. doi: 10.1172/JCI110055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Engfeldt P., Arner P., Ostman J. Studies on the regulation of phosphodiesterase in human adipose tissue in vitro. J Clin Endocrinol Metab. 1983 Mar;56(3):501–506. doi: 10.1210/jcem-56-3-501. [DOI] [PubMed] [Google Scholar]
  8. Fain J. N., Garcĩa-Sáinz J. A. Adrenergic regulation of adipocyte metabolism. J Lipid Res. 1983 Aug;24(8):945–966. [PubMed] [Google Scholar]
  9. Galitzky J., Taouis M., Berlan M., Rivière D., Garrigues M., Lafontan M. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest. 1988 Dec;18(6):587–594. doi: 10.1111/j.1365-2362.1988.tb01272.x. [DOI] [PubMed] [Google Scholar]
  10. Hellmér J., Arner P., Lundin A. Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem. 1989 Feb 15;177(1):132–137. doi: 10.1016/0003-2697(89)90027-4. [DOI] [PubMed] [Google Scholar]
  11. Hickner R. C., Rosdahl H., Borg I., Ungerstedt U., Jorfeldt L., Henriksson J. Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: dialysate glucose concentration is blood-flow-dependent. Acta Physiol Scand. 1991 Nov;143(3):355–356. doi: 10.1111/j.1748-1716.1991.tb09243.x. [DOI] [PubMed] [Google Scholar]
  12. Jansson P. A., Smith U., Lönnroth P. Interstitial glycerol concentration measured by microdialysis in two subcutaneous regions in humans. Am J Physiol. 1990 Jun;258(6 Pt 1):E918–E922. doi: 10.1152/ajpendo.1990.258.6.E918. [DOI] [PubMed] [Google Scholar]
  13. Linde B., Hjemdahl P. Effect of tilting on adipose tissue vascular resistance and sympathetic activity in humans. Am J Physiol. 1982 Feb;242(2):H161–H167. doi: 10.1152/ajpheart.1982.242.2.H161. [DOI] [PubMed] [Google Scholar]
  14. Lönnroth P., Jansson P. A., Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol. 1987 Aug;253(2 Pt 1):E228–E231. doi: 10.1152/ajpendo.1987.253.2.E228. [DOI] [PubMed] [Google Scholar]
  15. Mauriege P., Galitzky J., Berlan M., Lafontan M. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest. 1987 Apr;17(2):156–165. doi: 10.1111/j.1365-2362.1987.tb02395.x. [DOI] [PubMed] [Google Scholar]
  16. McGrath J. C., Brown C. M., Wilson V. G. Alpha-adrenoceptors: a critical review. Med Res Rev. 1989 Oct-Dec;9(4):407–533. doi: 10.1002/med.2610090403. [DOI] [PubMed] [Google Scholar]
  17. Richelsen B., Pedersen O. Alpha 2-adrenergic binding and action in human adipocytes. Comparison between binding to plasma membrane preparations and to intact adipocytes. Eur J Pharmacol. 1985 Dec 10;119(1-2):101–112. doi: 10.1016/0014-2999(85)90327-9. [DOI] [PubMed] [Google Scholar]
  18. Richelsen B., Pedersen S. B., Møller-Pedersen T., Bak J. F. Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism. 1991 Sep;40(9):990–996. doi: 10.1016/0026-0495(91)90078-b. [DOI] [PubMed] [Google Scholar]
  19. Tossman U., Ungerstedt U. Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand. 1986 Sep;128(1):9–14. doi: 10.1111/j.1748-1716.1986.tb07943.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES